Warfarin and heparin monitoring in antiphospholipid syndrome

2.

Devreese

KMJ

,

Ortel

TL

,

Pengo

V

,

de Laat

B

;

Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies

.

Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH

.

J Thromb Haemost

.

2018

;

16

(

4

):

809

-

813

.

3.

Petri

M.

Update on anti-phospholipid antibodies in SLE: the Hopkins’ Lupus Cohort

.

Lupus

.

2010

;

19

(

4

):

419

-

423

.

4.

Tektonidou

MG

,

Andreoli

L

,

Limper

M

, et al.

EULAR recommendations for the management of antiphospholipid syndrome in adults

.

Ann Rheum Dis

.

2019

;

78

(

10

):

1296

-

1304

.

5.

Legault

K

,

Schunemann

H

,

Hillis

C

, et al.

McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome

.

J Thromb Haemost

.

2018

;

16

(

8

):

1656

-

1664

.

6.

Garcia

D

,

Akl

EA

,

Carr

R

,

Kearon

C.

Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review

.

Blood

.

2013

;

122

(

5

):

817

-

824

.

7.

Kearon

C

,

Parpia

S

,

Spencer

FA

, et al.

Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism

.

Blood

.

2018

;

131

(

19

):

2151

-

2160

.

8.

Tektonidou

MG

,

Andreoli

L

,

Limper

M

,

Tincani

A

,

Ward

MM

.

Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults

.

RMD Open

.

2019

;

5

(

1

):

e000924

.

9.

Cohen

H

,

Isenberg

DA

.

How I treat anticoagulant-refractory thrombotic antiphospholipid syndrome

.

Blood

.

2021

;

137

(

3

):

299

-

309

.

10.

Cervera

R

,

Boffa

M-C

,

Khamashta

M-A

,

Hughes

G-R

.

The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe

.

Lupus

.

2009

;

18

(

10

):

889

-

893

.

11.

Khairani

CD

,

Bejjani

A

,

Piazza

G

, et al.

Direct oral anticoagulants vs vitamin K antagonists in patients with antiphospholipid syndromes: meta-analysis of randomized trials

.

J Am Coll Cardiol

.

2023

;

81

(

1

):

16

-

30

.

12.

Zuily

S

,

Cohen

H

,

Isenberg

D

, et al.

Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis

.

J Thromb Haemost

.

2020

;

18

(

9

):

2126

-

2137

.

13.

Woller

SC

,

Stevens

SM

,

Kaplan

DA

, et al.

Apixaban for the secondary prevention of thrombosis among patients with antiphospholipid syndrome: study rationale and design (ASTRO-APS)

.

Clin Appl Thromb Hemost

.

2016

;

22

(

3

):

239

-

247

.

14.

Mittal

P

,

Gafoor

R

,

Sayar

Z

, et al.

Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trial

.

Res Pract Thromb Haemost

.

2024

;

8

(

5

):

102468

.

15.

Dorgalaleh

A

,

Favaloro

EJ

,

Bahraini

M

,

Rad

F.

Standardization of prothrombin time/international normalized ratio (PT/INR)

.

Int J Lab Hematol

.

2021

;

43

(

1

):

21

-

28

.

16.

Tripodi

A

,

de Laat

B

,

Wahl

D

, et al;

Subcommittees on Control of Anticoagulation and Lupus Anticoagulant/Antiphospholipid Antibodies

.

Monitoring patients with the lupus anticoagulant while treated with vitamin K antagonists: communication from the SSC of the ISTH

.

J Thromb Haemost

.

2016

;

14

(

11

):

2304

-

2307

.

17.

Tripodi

A

,

Chantarangkul

V

,

Clerici

M

,

Negri

B

,

Galli

M

,

Mannucci

PM

.

Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins

.

Br J Haematol

.

2001

;

115

(

3

):

672

-

678

.

18.

Mulliez

SM

,

De Keyser

F

,

Verbist

C

, et al.

Lupus anticoagulant-hypoprothrombinemia syndrome: report of two cases and review of the literature

.

Lupus

.

2015

;

24

(

7

):

736

-

745

.

19.

Christensen

TD

,

Larsen

TB

.

Precision and accuracy of point-of-care testing coagulometers used for self-testing and self-management of oral anticoagulation therapy

.

J Thromb Haemost

.

2012

;

10

(

2

):

251

-

260

.

20.

Witt

DM

,

Nieuwlaat

R

,

Clark

NP

, et al.

American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy

.

Blood Adv

.

2018

;

2

(

22

):

3257

-

3291

.

21.

Taylor

JR

,

Richter

C

,

Lindamood

C

,

Liu

X

,

Zumberg

M

,

Fletcher

B.

Accuracy of CoaguChek XS in patients with antiphospholipid syndrome

.

Point Care

.

2017

;

16

(

4

):

161

-

163

.

22.

Isert

M

,

Miesbach

W

,

Schüttfort

G

, et al.

Monitoring anticoagulant therapy with vitamin K antagonists in patients with antiphospholipid syndrome

.

Ann Hematol

.

2015

;

94

(

8

):

1291

-

1299

.

23.

Jennings

I

,

Kitchen

D

,

Keeling

D

,

Fitzmaurice

D

,

Heneghan

C

;

BCSH Committee

.

Patient self-testing and self-management of oral anticoagulation with vitamin K antagonists: guidance from the British Committee for Standards in Haematology

.

Br J Haematol

.

2014

;

167

(

5

):

600

-

607

.

24.

Efthymiou

M

,

Lawrie

AS

,

Mackie

I

, et al.

Thrombin generation and factor X assays for the assessment of warfarin anticoagulation in thrombotic antiphospholipid syndrome

.

Thromb Res

.

2015

;

135

(

6

):

1191

-

1197

.

25.

Bick

RL

,

Rice

J.

Long-term outpatient dalteparin (fragmin) therapy for arterial and venous thrombosis: efficacy and safety–a preliminary report

.

Clin Appl Thromb Hemost

.

1999

;

5

(

suppl 1

):

S67

-

S71

.

26.

Vargas-Hitos

JA

,

Ateka-Barrutia

O

,

Sangle

S

,

Khamashta

MA

.

Efficacy and safety of long-term low molecular weight heparin in patients with antiphospholipid syndrome

.

Ann Rheum Dis

.

2011

;

70

(

9

):

1652

-

1654

.

27.

Carrier

M

,

Le Gal

G

,

Cho

R

,

Tierney

S

,

Rodger

M

,

Lee

AY

.

Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients

.

J Thromb Haemost

.

2009

;

7

(

5

):

760

-

765

.

28.

Gajic-Veljanoski

O

,

Phua

CW

,

Shah

PS

,

Cheung

AM

.

Effects of long-term low-molecular-weight heparin on fractures and bone density in non- pregnant adults: a systematic review with meta-analysis

.

J Gen Intern Med

.

2016

;

31

(

8

):

947

-

957

.

29.

American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics

.

ACOG Practice Bulletin No. 196: thromboembolism in pregnancy

.

Obstet Gynecol

.

2018

;

132

(

1

):

e1

-

e17

.

30.

Kourlaba

G

,

Relakis

J

,

Kontodimas

S

,

Holm

MV

,

Maniadakis

N.

A systematic review and meta-analysis of the epidemiology and burden of venous thromboembolism among pregnant women

.

Int J Gynaecol Obstet

.

2016

;

132

(

1

):

4

-

10

.

31.

Royal College of Obstetricians and Gynaecologists

. Green-top Guideline No. 37a.

Reducing the Risk of Thrombosis and Embolism During Pregnancy and the Puerperium

. RCOG;

2015

.

32.

Lamy

C

,

Hamon

JB

,

Coste

J

,

Mas

JL

.

Ischemic stroke in young women: risk of recurrence during subsequent pregnancies. French Study Group on Stroke in Pregnancy

.

Neurology

.

2000

;

55

(

2

):

269

-

274

.

33.

Liu

S

,

Rouleau

J

,

Joseph

KS

, et al.

Epidemiology of pregnancy-associated venous thromboembolism: a population-based study in Canada

.

J Obstet Gynaecol Can

.

2009

;

31

(

7

):

611

-

620

.

34.

Skeith

L.

Preventing venous thromboembolism during pregnancy and postpartum: crossing the threshold

.

Hematology Am Soc Hematol Educ Program

.

2017

;

2017

(

1

):

160

-

167

.

35.

Rodríguez-Pintó

I

,

Moitinho

M

,

Santacreu

I

, et al;

CAPS Registry Project Group (European Forum on Antiphospholipid Antibodies)

.

Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the International CAPS Registry

.

Autoimmun Rev

.

2016

;

15

(

12

):

1120

-

1124

.

36.

Garcia

DA

,

Baglin

TP

,

Weitz

JI

,

Samama

MM

.

Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

.

Chest

.

2012

;

141

(

2 Suppl

):

e24S

-

e43S

.

doi: 10.1378/chest.11-2291

. Erratum in: Chest. 2012;141(5):1369. Dosage error in article text. Erratum in: Chest. 2013;144(2):721. Dosage error in article text.

37.

Bates

SM

,

Rajasekhar

A

,

Middeldorp

S

, et al.

American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy

.

Blood Adv

.

2018

;

2

(

22

):

3317

-

3359

.

38.

Fouda

UM

,

Sayed

AM

,

Abdou

A-M

,

Ramadan

D-I

,

Fouda

I-M

,

Zaki

M-M

.

Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome

.

Int J Gynaecol Obstet

.

2011

;

112

(

3

):

211

-

215

.

39.

Sammaritano

LR

,

Bermas

BL

,

Chakravarty

EE

, et al.

2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases

.

Arthritis Rheumatol

.

2020

;

72

(

4

):

529

-

556

.

40.

Fischer-Betz

R

,

Specker

C

,

Brinks

R

,

Schneider

M.

Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study

.

Lupus

.

2012

;

21

(

11

):

1183

-

1189

.

41.

Stone

S

,

Hunt

BJ

,

Khamashta

MA

,

Bewley

SJ

,

Nelson-Piercy

C.

Primary antiphospholipid syndrome in pregnancy: an analysis of outcome in a cohort of 33 women treated with a rigorous protocol

.

J Thromb Haemost

.

2005

;

3

(

2

):

243

-

245

.

42.

Royal College of Obstetricians and Gynaecologists

. Green-top Guideline No. 37b.

Thrombosis and Embolism During Pregnancy and the Puerperium: Acute Management

.

RCOG, London

(

2015

).

43.

Yelnik

CM

,

Lambert

M

,

Drumez

E

, et al.

Bleeding complications and antithrombotic treatment in 264 pregnancies in antiphospholipid syndrome

.

Lupus

.

2018

;

27

(

10

):

1679

-

1686

.

44.

Robertson

L

,

Strachan

J.

Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism

.

Cochrane Database Syst Rev

.

2017

;

2

(

2

):

CD006771

.

45.

Cuker

A

,

Arepally

GM

,

Chong

BH

, et al.

American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia

.

Blood Adv

.

2018

;

2

(

22

):

3360

-

3392

.

46.

Konstantinides

SV

,

Meyer

G

,

Becattini

C

, et al;

ESC Scientific Document Group

.

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)

.

Eur Heart J

.

2020

;

41

(

4

):

543

-

603

.

47.

Shore-Lesserson

L

,

Baker

RA

,

Ferraris

VA

, et al.

The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: clinical practice guidelines-anticoagulation during cardiopulmonary bypass

.

Ann Thorac Surg

.

2018

;

105

(

2

):

650

-

662

.

48.

Kitchen

S

,

Gray

E

,

Mackie

I

,

Baglin

T

,

Makris

M

;

BCSH Committee

.

Measurement of non-coumarin anticoagulants and their effects on tests of haemostasis: guidance from the British Committee for Standards in Haematology

.

Br J Haematol

.

2014

;

166

(

6

):

830

-

841

.

49.

Greaves

M

;

Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis

.

Limitations of the laboratory monitoring of heparin therapy. Scientific and standardization committee communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis

.

Thromb Haemost

.

2002

;

87

(

1

):

163

-

164

.

50.

Devreese

KM

,

Verfaillie

CJ

,

De Bisschop

F

,

Delanghe

JR

.

Interference of C-reactive protein with clotting times

.

Clin Chem Lab Med

.

2015

;

53

(

5

):

e141

-

e145

.

51.

Mehta

TP

,

Smythe

MA

,

Mattson

JC

.

Strategies for managing heparin therapy in patients with antiphospholipid antibody syndrome

.

Pharmacotherapy

.

2011

;

31

(

12

):

1221

-

1231

.

52.

Cohen

H

,

Efthymiou

M

,

Devreese

KMJ

.

Monitoring of anticoagulation in thrombotic antiphospholipid syndrome

.

J Thromb Haemost

.

2021

;

19

(

4

):

892

-

908

.